- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14.08. | Appeals Court Sides with Providers in No Surprises Act Pay Dispute | ||
| 14.08. | Cotiviti Launches AI Solution to Address Coordination of Benefits Issues | ||
| 13.08. | PTC Therapeutics' $211M Bid Wins Bankruptcy Auction for Sangamo Gene Therapy | ||
| 13.08. | Founders Should Stop Worrying If They're "AI Enough" | ||
| 13.08. | New Startup Launches to Close the Bedside Communication Gap in Hospitals | ||
| 13.08. | Report: Employers' Use of Big Three PBMs Falls in 2026 | ||
| 12.08. | Startup Boulevard Bio Launches With Immune Reset Pioneer Schett as Co-Founder | ||
| 12.08. | Ambulatory Growth Demands a New Operating Model | ||
| 12.08. | Health IT Vendor's Data Breach Exposes Nearly 4M Patient Records | ||
| 12.08. | NOCD Announces Plans for National Expansion of Intensive Outpatient Therapy | ||
| 11.08. | Infinimmune Secures $75M for a More Human Approach to Developing Better Antibody Drugs | ||
| 11.08. | From Friction to Fix: Measuring What's Breaking Payer-Provider Trust | ||
| 11.08. | Which Health Tech Companies Are Getting Customer Experience Right? | ||
| 11.08. | How CMS Is Tackling 'Coverage Purgatory' for Medical Devices | ||
| 11.08. | Amazon Pharmacy Executive: Formularies are Anti-Choice | ||
| 11.08. | Small Businesses Could Face Double-Digit Premium Hikes in 2027 | ||
| 11.08. | Jazz Pharma Expands Again in Epilepsy With $850M Actio Bio Acquisition | ||
| 10.08. | MedCity Pivot: How Aetna is Adopting Agentic AI | ||
| 10.08. | AI in Drug Development is Not a Data Problem - It's An Evidence Problem | ||
| 10.08. | How to Keep Clinicians Satisfied, the Ascension Way | ||
| 10.08. | Compliance Alone Won't Fix the Home Health Fraud Problem | ||
| 10.08. | Braveheart Bio's $382M IPO for Heart Drug Leads a Big Week for Biotech IPOs | ||
| 10.08. | MedCity FemFwd: Employer Strategies for Women's Health | ||
| 10.08. | Two Differing POVs Emerge About the Hinge-Cylinder Deal | ||
| 10.08. | Latigo Bio's IPO Lands $346M for Pipeline of Non-Opioid Pain Drugs |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.